How many institutional investors hold NMRA?

3 tracked institutional investors disclosed a position in NMRA (NEUMORA THERAPEUTICS INC.) in their most recent 13F filing.

Who is the largest institutional holder of NMRA?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in NMRA, valued at $16M.

Where does this NMRA ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

NMRA — NEUMORA THERAPEUTICS INC.

Name: NEUMORA THERAPEUTICS INC. (NMRA) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying NMRA?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Strong distribution · 0 buying vs 1 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their NMRA position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence

+3 tracked investors reported holding NMRA at their latest filing
+Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About NEUMORA THERAPEUTICS INC. (NMRA)

NEUMORA THERAPEUTICS INC. (NMRA) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $16M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in NMRA

/100

Institutional Accumulation

Added / Increased2

Reduced0

Exited1

BearishBullish

Crowded Trade Score™

How many top investors track NMRA

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

NMRA Ownership Composition

How NEUMORA THERAPEUTICS INC. is held across tracked investor types, based on reported 13F positions.

Dominant Type

Macro

77% of tracked value

Institutions

tracked investors

Total Reported

$11.5M

combined 13F value

Macro76.7%
Multi-Strategy / Quant23.3%

Macro(1)

76.7%

Multi-Strategy / Quant(2)

23.3%

Tracked investors currently reporting NMRA

1 tracked investor has since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	509.2K	$865.7K	0.00%	Jun 30, 2026
Paul Tudor Jones	Tudor Investment Corp	5.2M	$8.8M	0.01%	Jun 30, 2026
Ken Griffin	Citadel Advisors	1.1M	$1.8M	0.00%	Jun 30, 2026

Izzy EnglanderJun 30, 2026
Millennium Management
Shares
509.2K
Value
$865.7K
% Portfolio
0.00%
Paul Tudor JonesJun 30, 2026
Tudor Investment Corp
Shares
5.2M
Value
$8.8M
% Portfolio
0.01%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
1.1M
Value
$1.8M
% Portfolio
0.00%

Previously held NMRA

These investors reported NMRA in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Steve Cohen	Point72 Asset Management	602.4K	$1.2M	Mar 31, 2026

Recent activity

Investor	Action	Δ %	Current value	Filing date
Steve Cohen	New	—	$1.1M	Nov 14, 2024
Steve Cohen	Increased	1705.55%	$15.9M	Feb 14, 2025
Steve Cohen	Sold	-100.00%	$0	Jul 21, 2025

Steve Cohen
New
$1.1MNov 14, 2024
Steve Cohen
Increased
$15.9M(1705.55%)Feb 14, 2025
Steve Cohen
Sold
$0(-100.00%)Jul 21, 2025

Frequently asked questions

How many institutional investors hold NMRA?: 3 tracked institutional investors disclosed a position in NMRA (NEUMORA THERAPEUTICS INC.) in their most recent 13F filing.
Who is the largest institutional holder of NMRA?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in NMRA, valued at $16M.
Did institutional ownership of NMRA increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 1 fully exited NMRA.
Where does this NMRA ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.